Zu Zhang, MD
Family Medicine · Chamblee, GANPI 1194935510
Payments from drug & device makers
Across 136 payments — averaging $26.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$496
- Biohaven Pharmaceuticals, Inc.$483
- Lilly USA, LLC$372
- Novo Nordisk$288
- Abbott$233
- Amgen$205
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,56397%
- Education$1023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $496 |
| Biohaven Pharmaceuticals, Inc. | 9 | $483 |
| Lilly USA, LLC | 19 | $372 |
| Novo Nordisk | 17 | $288 |
| Abbott | 7 | $233 |
| Amgen(2 entities) | 6 | $205 |
| Gilead | 7 | $195 |
| Bayer | 10 | $185 |
| Astellas Pharma US Inc | 7 | $174 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Eisai Inc. | 2 | $115 |
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| GSK | 4 | $88 |
| Amarin Pharma, Inc. | 5 | $87 |
| Merz North America, Inc. | 1 | $83 |
| AbbVie | 4 | $71 |
| Boehringer Ingelheim | 3 | $54 |
| Dexcom, Inc. | 3 | $45 |
| Exact Sciences | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Echosens North America, Inc. | 2 | $33 |
| Evoke Pharma, Inc. | 2 | $30 |
| Novartis | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Merck | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$375
- FreeStyle Libre 2$142
- TARPEYO$125
- Otezla$125
- BREZTRI$122
- AIRSUPRA$115
- FARXIGA$103
How this compares
$3,665 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 20 | $46,502 |
| EliquisApixaban | 32 | $40,981 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $38,519 |
| OzempicSemaglutide | 20 | $37,848 |
| JardianceEmpagliflozin | 18 | $30,630 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $7,544 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $4,378 |
| Lidocaine | 34 | $3,358 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $2,006 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,832 |
| Omega-3 Acid Ethyl Esters | 20 | $1,793 |
| Diclofenac Sodium | 47 | $1,410 |
| Nifedipine ErNifedipine | 16 | $1,079 |
| Atorvastatin Calcium | 194 | $989 |
| Amlodipine Besylate | 222 | $979 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $372 | $46,50220 claims |
| GSKTrelegy Ellipta | $88 | $38,51941 claims |
| Novo NordiskOzempic | $288 | $37,84820 claims |
| Boehringer IngelheimJardiance | $54 | $30,63018 claims |
| MerckJanumet Xr | $16 | $7,54412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Chamblee
- Hong LiChamblee$331K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.